• Home
  • Contact Us
  • Français
  • About Us
    • Vision
    • Who We Are
    • Why Choose King
    • Strategy
    • Fast Facts
  • |
  • Products
    • EpiPen.ca
    • Cytomel
  • |
  • Newsroom
    • FAQs
  • |
  • Business Development
  • Vision
  • Who We Are
  • Why Choose King
  • Strategy
  • Fast Facts

About Us

Vision

King strives to be a recognized leader and partner of choice in bringing innovative, clinically-differentiated therapies and technologies to market in cardiovascular/metabolics, neuroscience and hospital/acute care.

Who We Are

King is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in the therapeutic areas of cardiovascular/metabolics, neuroscience and hospital/acute care.

Why Choose King?

King's business model offers the best of a big and small company in one fully integrated pharmaceutical company. King is an agile corporation whose size enables it to build close, personal one-on-one relationships with business development partners and move quickly to capitalize on scientific advances that address patient needs.

Strategy

King is achieving its vision through an enterprise-wide focus on three core therapeutic areas, organic growth and a disciplined business development process.

Fast Facts about King.

  • Home
  • About Us
  • Products
  • Newsroom
  • Business Development
  • Contact Us
  • Site Map
  • Legal
  • King Pharmaceuticals, Inc.

©2011 King Pharmaceuticals,® Inc. All rights reserved.

 

King Pharmaceuticals is now part of Pfizer Inc. The integration of King and Pfizer entities may be pending in various local jurisdictions and integration may be subject to completion of various local legal and regulatory obligations. All content in this message is subject to works council and/or union consultations, if applicable, and other legal requirements where appropriate.